# NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

> **NCT06593327** · NA · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Type 2 Diabetes
- Diabetic Cardiomyopathy
- Heart Failure
- Cardiometabolic Diseases

## Interventions

- **BEHAVIORAL:** Intensive Prevention Strategy

## Key facts

- **NCT ID:** NCT06593327
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2027-12-10
- **Final completion:** 2027-12-15
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06593327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06593327, "NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06593327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
